Disease | metabolic syndrome x |
Comorbidity | C0010068|coronary heart disease |
Sentences | 16 |
PubMedID- 21186101 | This study evaluates the association of incident clinical coronary heart disease with metabolic syndrome and each of its individual defining components in a sample of spanish working males. |
PubMedID- 22548293 | metabolic syndrome is associated with coronary heart disease (chd) and new-onset diabetes after kidney transplant (nodat). |
PubMedID- 19969373 | Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the heart and soul study. |
PubMedID- 22906266 | Associations between coronary heart disease and individual components of the metabolic syndrome according to glucose tolerance status. |
PubMedID- 21153653 | Obesity does not appear to be an independent predictor for the 10-year risk of coronary heart disease events in patients without metabolic syndrome treated with second-generation antipsychotics. |
PubMedID- 23479983 | Aim: to identify the factors most substantially influencing the quality of life (ql) in patients with coronary heart disease (chd) associated with metabolic syndrome (ms), by using the principal component method. |
PubMedID- 21148595 | Dual role of physical workload and occupational noise in the association of the metabolic syndrome with risk of coronary heart disease: findings from the helsinki heart study. |
PubMedID- 21636030 | We also discuss that a healthy lifestyle is essential for preventing and treating chronic kidney disease and coronary heart disease seen in patients with metabolic syndrome. |
PubMedID- 19935427 | The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. |
PubMedID- 24793349 | Background and objectives: to evaluate the risk of coronary heart disease (chd) associated with metabolic syndrome (mets) and its individual components in a representative sample of diabetic and nondiabetic iranians. |
PubMedID- 23251156 | The increased risk of coronary heart disease in patients with the metabolic syndrome suggests that the insulin-resistant state is atherogenic without concomitant elevations in plasma glucose and glycosylated hemoglobin [26, 27]. |
PubMedID- 26401840 | Correction: the relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function - an occupational cohort-based study. |
PubMedID- 26274823 | The relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function--an occupational cohort-based study. |
PubMedID- 23819342 | [comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome]. |
PubMedID- 21139493 | Procollagen iii n-terminal peptide predicts short-term prognosis and cardiac remodeling in coronary heart disease patients with metabolic syndrome. |
PubMedID- 23091851 | Aim: to define the pharmacogenetic features of the effect of metformin in coronary heart disease (chd) patients with metabolic syndrome (ms) or type 2 diabetes mellitus (t2dm), by taking into consideration ppar-gamma2 pro1 2ala polymorphism. |
Page: 1